Last reviewed · How we verify

Use of insulin glargine once daily — Competitive Intelligence Brief

Use of insulin glargine once daily (Use of insulin glargine once daily) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed Small molecule Live · refreshed every 30 min

Target snapshot

Use of insulin glargine once daily (Use of insulin glargine once daily) — Eastern Virginia Medical School.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Use of insulin glargine once daily TARGET Use of insulin glargine once daily Eastern Virginia Medical School marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Use of insulin glargine once daily — Competitive Intelligence Brief. https://druglandscape.com/ci/use-of-insulin-glargine-once-daily. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: